- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | FDA Rejects Tricida Chronic Kidney Disease Drug, More Data Needed | ||
| Di | FDA Adds Plasma as 2nd COVID-19 Treatment Under Emergency Guidelines | ||
| Mo | Yumanity to Merge With Proteostasis to Advance Neuro Drug Pipeline | ||
| Fr | Astellas Reports Third Patient Death in Audentes Gene Therapy Study | ||
| Fr | Bio Roundup: J&J Buyout, BioMarin Rebuffed, Poseida on Hold & More | ||
| Fr | Harmony Bio and Inhibrx Raise Combined $247M in Public Market Debuts | ||
| Do | Final Agenda Released for the Xcelerate Keynote Series at Biotech Week Boston | ||
| Do | Final Agenda Now Live for the Xcelerate Keynote Series at Biotech Week Boston | ||
| Do | Alzheon Lands $47M to Take Another Shot at a Pivotal Alzheimer's Test | ||
| Do | FDA Rejects BioMarin Hemophilia Gene Therapy, Asks for More Data | ||
| 19.08. | J&J Boosts Autoimmune Disease Drug Pipeline With $6.5B Momenta Buyout | ||
| 19.08. | Patient Death in Poseida Prostate Cancer Study Prompts Clinical Hold | ||
| 18.08. | Unity Biotech Arthritis Drug Flunks Phase 2, Spelling Program's End | ||
| 18.08. | Genentech Gets FDA OK for Injectable Rare Neuroimmune Disease Drug | ||
| 18.08. | Tango Therapeutics Adds $175M, Deal Turns Partner Gilead Into Investor | ||
| 17.08. | Bristol Myers Squibb to Splash Out $475M on Dragonfly Immunotherapy | ||
| 17.08. | Sanofi Reaches $3.68B Deal to Buy Principia and Partnered MS Drug | ||
| 15.08. | Advisory Body Backs MesoBlast Therapy for Transplant Complication | ||
| 15.08. | CureVac's IPO Hauls In $213M as Key mRNA COVID-19 Vaccine Test Nears | ||
| 14.08. | Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More | ||
| 13.08. | With FDA Nod, NS Pharma Duchenne Drug Becomes Sarepta Competitor | ||
| 12.08. | Perceptive Advisors' LianBio Inks Deals With BridgeBio, MyoKardia | ||
| 12.08. | F2G Lands $60M for a New Tack on Taking Out Rare Fungal Infections | ||
| 12.08. | Pfizer's Bourla: There's Coronavirus Vaccine Pressure, But It's Not Political | ||
| 11.08. | Ligand to Spend $438M to Add Protein Maker Pfenex to Technology Lineup |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
